Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer
- 2 October 2023
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 118 (4) , 963-970
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (CA252010)
- U.S. Department of Veterans Affairs (I01 BX005267, VA 150CU000182)
- LUNGevity Foundation (2022-14)
- Melanoma Research Alliance (MRA 689853)
This publication has 37 references indexed in Scilit:
- Association of Target Volume Margins With Locoregional Control and Acute Toxicities for Non-small cell lung cancer Treated With Concurrent Chemoradiation TherapyPractical Radiation Oncology, 2019
- Radiation Pneumonitis: Old Problem, New TricksCancers, 2018
- Corrections to “Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2018
- Validating the use of veterans affairs tobacco health factors for assessing change in smoking status: accuracy, availability, and approachBMC Medical Research Methodology, 2018
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung CancerNew England Journal of Medicine, 2017
- Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical TrialJournal of Clinical Oncology, 2017
- Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced CancerJAMA Oncology, 2016
- Reporting Discrepancies Between the ClinicalTrials.gov Results Database and Peer-Reviewed PublicationsAnnals of Internal Medicine, 2014
- Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysisInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Radiation pneumonitis in patients with lung and mediastinal tumours: a retrospective study of risk factors focused on pulmonary emphysemaBritish Journal of Radiology, 2012